BRATTON DOUGLAS K

CIK 00012819334 companiesFORT WORTH, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001281933

Recent Transactions

50 trades

Gift
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-12-02−40,000→ 199,841 total
Award
MIDWEST HOLDING INC.
Voting Common Stock
2022-06-14+2,674→ 447,845 total
Award
MIDWEST HOLDING INC.
Voting Common Stock
2021-11-11+727→ 445,171 total
Other
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-12−97,598→ 2,657,943 total
Other
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-12−564,160→ 3,468,747 total
Other
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-12−524,675→ 1,688,639 total
Other
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-12−2,249,077→ 0 total
Other
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-12−40,404→ 47,051 total
Other
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-12+1,783,578→ 1,948,578 total
Gift
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-03-09−62,500→ 12,585 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2021-02-12$65.00/sh−2,216,798→ 9,984,836 total
Other
Denali Therapeutics Inc.$DNLI
Common Stock
2020-12-21−383,411→ 0 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-12-14$80.35/sh−16,949→ 384,287 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-12-14$81.13/sh−876→ 383,411 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-12-11$80.05/sh−46,799→ 401,236 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-08-12$31.65/sh−1,443,247→ 12,201,634 total
Award
MIDWEST HOLDING INC.
Stock Option (right to buy)
2020-07-31+50,000→ 50,000 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-30$24.34/sh−200→ 448,035 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-30$24.01/sh−45,145→ 448,235 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-29$23.84/sh−61,807→ 514,151 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-29$24.50/sh−20,771→ 493,380 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-26$24.67/sh−13,604→ 575,958 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-26$23.84/sh−108,473→ 589,562 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-23$26.19/sh−3,247→ 698,035 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-23$25.69/sh−16,777→ 701,282 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-22$25.12/sh−24,683→ 718,059 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-22$24.66/sh−65,373→ 742,742 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-19$24.20/sh−82,481→ 870,554 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-19$25.00/sh−62,439→ 808,115 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2020-06-16+14,000→ 14,000 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-06-05$25.75/sh−1,922,855→ 13,644,881 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2020-02-26$20.25/sh−3,894,764→ 15,567,736 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2019-06-13+13,350→ 13,350 total
Other
Denali Therapeutics Inc.$DNLI
Common Stock
2019-03-25−158,764→ 953,035 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2018-07-24$15.00/sh+165,000→ 165,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2018-07-24+26,700→ 26,700 total
Conversion
Denali Therapeutics Inc.$DNLI
Series A-2 Convertible Preferred Stock
2017-12-12−128,200→ 0 total
Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12+2,500,000→ 17,312,499 total
Conversion
Denali Therapeutics Inc.$DNLI
Series B-1 Convertible Preferred Stock
2017-12-12−240,000→ 0 total
Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12+14,499,999→ 14,812,499 total
Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12+128,200→ 871,799 total
Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12+240,000→ 1,111,799 total
Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12+1,875,000→ 19,187,499 total
Conversion
Denali Therapeutics Inc.$DNLI
Series A-1 Convertible Preferred Stock
2017-12-12−14,499,999→ 0 total
Conversion
Denali Therapeutics Inc.$DNLI
Series A-2 Convertible Preferred Stock
2017-12-12−2,500,000→ 0 total
Conversion
Denali Therapeutics Inc.$DNLI
Series A-1 Convertible Preferred Stock
2017-12-12−743,599→ 0 total
Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12+743,599→ 743,599 total
Purchase
Denali Therapeutics Inc.$DNLI
Common Stock
2017-12-12$18.00/sh+275,000→ 19,462,499 total
Conversion
Denali Therapeutics Inc.$DNLI
Series B-1 Convertible Preferred Stock
2017-12-12−1,875,000→ 0 total
Sale
Juno Therapeutics, Inc.
Common Stock
2017-07-13$27.00/sh−8,000,000→ 9,166,130 total

Companies

Recent Filings

Address

201 MAIN STREET, SUITE 1900

FORT WORTH, TX, 76102

View on SEC.gov